First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Navigating the Landscape of Drug Formularies and Prescribing and Treatment Guidelines
Over the course of the next several years we can expect more and more jurisdictions to move towards adoption of legislative and/or regulatory measures
Mitchell and Genex Services Finalize Merger
Merger establishes complete suite of medical compliance, cost containment and clinical solutions enhancing collective capabilities to create even
Mitchell Diagnostics System Surpasses Quarter Million Repair Scan Milestone; Freedom Platform Extended
SAN DIEGO, CA—Mitchell International, Inc., a leading provider of technology, connectivity and information solutions to the
Risk & Insurance: Starbucks' Workers' Comp Program Earns a Teddy Award for Its Exceptional Employee Advocacy
In just four years, Starbucks Coffee Company changed the way workers' comp claims were handled by placing the process in the hands of their p
Montana to Hold Hearing on Proposed Drug Formulary Rule
The Montana Department of Labor and Industry (DLI) published draft drug formulary and treatment guideline rules and amendments in early October.
The Growing Federal and State Challenges of Medical Marijuana
As of October 2018 a total of 29 states and the District of Columbia currently allow for medical marijuana and cannabis programs.